Abstract

Almost all haemodialysis patients are treated with parenteral iron to compensate for blood loss and to allow the full therapeutic effect of erythropoiesis-stimulating agents. Iron overload is an increasingly recognised clinical situation diagnosed by quantitative magnetic resonance imaging (MRI). MRI methods have not been fully validated in dialysis patients. We compared Deugnier’s and Turlin’s histological scoring of iron overload and Scheuer’s classification (with Perls’ stain) with three quantitative MRI methods for measuring liver iron concentration (LIC)—signal intensity ratio (SIR), R2* relaxometry, and R2* multi-peak spectral modelling (Iterative Decomposition of water and fat with Echo Asymmetry and Least-squares estimation (IDEAL-IQ®)) relaxometry—in 16 haemodialysis patients in whom a liver biopsy was formally indicated for medical follow-up. LIC MRI with these three different methods was highly correlated with Deugnier’s and Turlin’s histological scoring (SIR: r = 0.8329, p = 0.0002; R2* relaxometry: r = −0.9099, p < 0.0001; R2* relaxometry (IDEAL-IQ®): r = −0.872, p = 0.0018). Scheuer’s classification was also significantly correlated with these three MRI techniques. The positive likelihood ratio for the diagnosis of abnormal LIC by Deugnier’s histological scoring was > 62 for the three MRI methods. This study supports the accuracy of quantitative MRI methods for the non-invasive diagnosis and follow-up of iron overload in haemodialysis patients.

Highlights

  • The discovery of epoetin 30 years ago represented a therapeutic revolution in end-stage kidney disease (ESKD), allowing the partial correction of anaemia in most patients and the avoidance of blood transfusion with its corollary of human leucocyte antigen (HLA) sensitisation and transfusion-related iron overload, deeply transforming the quality of life and clinical outcomes of ESKD patients [1,2]

  • liver iron concentration (LIC) was assessed by three quantitative magnetic resonance imaging (MRI) methods simultaneously—signal intensity ratio (SIR) according to Rennes University, R2* relaxometry, and R2* relaxometry with multi-peak spectral modelling (IDEAL-IQ® )—according to the manufacturer [16,18,19]

  • MRI methods (SIR according to Rennes University, R2* relaxometry and R2* relaxometry with multi-peak spectral modelling) and quantitative histological estimation of iron load in 16 with multi-peak spectral modelling) and quantitative histological estimation of iron load in 16 haemodialysis patients

Read more

Summary

Introduction

The discovery of epoetin 30 years ago represented a therapeutic revolution in end-stage kidney disease (ESKD), allowing the partial correction of anaemia in most patients and the avoidance of blood transfusion with its corollary of human leucocyte antigen (HLA) sensitisation and transfusion-related iron overload, deeply transforming the quality of life and clinical outcomes of ESKD patients [1,2].Almost all haemodialysis patients receive parenteral iron to ensure efficient erythropoiesis with erythropoiesis-stimulating agents (ESAs) in order to overcome functional iron deficiency and to compensate true iron deficiency related to important blood loss in the setting of dialysis [1,2].J. The discovery of epoetin 30 years ago represented a therapeutic revolution in end-stage kidney disease (ESKD), allowing the partial correction of anaemia in most patients and the avoidance of blood transfusion with its corollary of human leucocyte antigen (HLA) sensitisation and transfusion-related iron overload, deeply transforming the quality of life and clinical outcomes of ESKD patients [1,2]. Almost all haemodialysis patients receive parenteral iron to ensure efficient erythropoiesis with erythropoiesis-stimulating agents (ESAs) in order to overcome functional iron deficiency and to compensate true iron deficiency related to important blood loss in the setting of dialysis [1,2].

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call